Aignostics
GermanyWho owns Aignostics?
Aignostics is a German HealthTech company, currently owned by Wellington Partners since 2022 and 3 other investors.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Key facts
- ·Co-held by IBB Ventures, Boehringer Ingelheim Venture Fund, High-Tech Gruenderfonds (HTGF) and Wellington Partners since 2020.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
More from HTGF III
Other portfolio companies in the same fund.
UK
SwitzerlandMore PE-backed in HealthTech
Comparable healthtech deals from other GPs.
US
Questions
Who owns Aignostics?
Aignostics is currently owned by Wellington Partners, IBB Ventures and 2 others, through HTGF III, since 2022.
When did Wellington Partners and 3 others acquire Aignostics?
Wellington Partners and 3 others acquired Aignostics in 2022.
Who has owned Aignostics over time?
Aignostics has been through 4 private-equity ownership periods: IBB Ventures · via VC Fonds Technologie Berlin · since 2020; Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2020; High-Tech Gruenderfonds (HTGF) · via HTGF III · since 2020; Wellington Partners · via Wellington Partners Life Sciences · since 2022.